SC
AAPG

Steven Cohen’s Ascentage Pharma AAPG Stock Holding History

Steven Cohen’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
13,841
-2,215
-14% -$47.2K ﹤0.01% 3455
2026
Q1 		$383K Sell
16,056
-670
-4% -$16.5K ﹤0.01% 3253
2025
Q4 		$439K Buy
+16,726
New +$548K ﹤0.01% 3300

Other funds holding AAPG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Steven Cohen's AAPG Position: Q2 2026 in Review

Steven Cohen reduced its Ascentage Pharma (AAPG) stake by 14% in Q2 2026, selling an estimated $47.2K and leaving 13,841 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3455.

Steven Cohen first reported a position in AAPG in Q4 2025 and has held it in 3 quarters since. The position peaked at $439K in Q4 2025. 8 funds tracked by Wall St. Rank hold AAPG as of Q2 2026.

  • Steven Cohen held 13,841 shares of Ascentage Pharma worth $243K as of Q2 2026.
  • Steven Cohen sold 2,215 Ascentage Pharma shares in Q2 2026, an estimated $47.2K.
  • Ascentage Pharma made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3455 holding.
  • Steven Cohen first reported a position in Ascentage Pharma in Q4 2025 and has held it in 3 quarters since.
  • Steven Cohen's Ascentage Pharma position peaked at $439K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Ascentage Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.